Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Medtronic (MDT) PT Raised to $90 at Jefferies on 'Very Good' Q3February 18, 2015 7:51 AM Medtronic (MDT) Reports Q3 EPS of $1.04February 17, 2015 7:16 AM